title: A 16-year-old boy with severe gamma-butyrolactone (GBL) withdrawal delirium.
authors.forename: F D
authors.initials: FD
authors.lastname: Zepf
authors.forename: M
authors.initials: M
authors.lastname: Holtmann
authors.forename: E
authors.initials: E
authors.lastname: Duketis
authors.forename: J
authors.initials: J
authors.lastname: Maier
authors.forename: D
authors.initials: D
authors.lastname: Radeloff
authors.forename: A
authors.initials: A
authors.lastname: Wagner
authors.forename: F
authors.initials: F
authors.lastname: Poustka
authors.forename: L
authors.initials: L
authors.lastname: Wöckel
mesh_terms: D015107:4-Butyrolactone / Q000009:adverse effects*; D000293:Adolescent; D002491:Central Nervous System Agents / Q000009:adverse effects*; D003693:Delirium / Q000139:chemically induced*; D006801:Humans; D008297:Male; D013375:Substance Withdrawal Syndrome / Q000628:therapy; D016896:Treatment Outcome
chemical_list: D002491:Central Nervous System Agents; D015107:4-Butyrolactone